Ruth Z. Rutledge

7.1k citations

16 papers · 735 indexed · h-index 14

Molecular Biology
Organic Chemistry top 10%
Psychiatry and Mental health top 10%
Cellular and Molecular Neuroscience top 10%
Oncology

Co-authors: Kenneth A. Thomas Randall W. Hungate Richard Kendall Andrew J. Tebben Stefanie A. Kane Kenneth S. Koblan Lars Edvinsson Jenny Longmore
Topics: Migraine and Headache Studies (5 papers)Cancer Treatment and Pharmacology (5 papers)HER2/EGFR in Cancer Research (4 papers)
Cited by: Psychiatry and Mental health Cellular and Molecular Neuroscience Organic Chemistry
Journals: Journal of Biological Chemistry Journal of Clinical Oncology Blood
Partner nations: United States United Kingdom Spain

In The Last Decade

Ruth Z. Rutledge

16 papers receiving 699 citations

Peers

Countries citing papers authored by Ruth Z. Rutledge

Since Specialization

Citations

This map shows the geographic impact of Ruth Z. Rutledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Z. Rutledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Z. Rutledge more than expected).

Fields of papers citing papers by Ruth Z. Rutledge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Z. Rutledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Z. Rutledge. The network helps show where Ruth Z. Rutledge may publish in the future.

Co-authorship network of co-authors of Ruth Z. Rutledge

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Z. Rutledge. A scholar is included among the top collaborators of Ruth Z. Rutledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Z. Rutledge. Ruth Z. Rutledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) 2020 ·Blood ·Robert M. Rifkin,Kevin Boyd,Sebastian Grosicki,Kihyun Kım,Francesco Di Raimondo,Meletios Α. Dimopoulos,Katja Weisel,Bertrand Arnulf,Roman Hájek,(unknown),Andrew Spencer,Randy Davis,Antonio Riccio,(unknown),(unknown),Ruth Z. Rutledge,Mala K. Talekar,Brandon E. Kremer,Ira Gupta,María‐Victoria Mateos	13
2	Optimizing PD-L1 as a biomarker of response with pembrolizumab (pembro; MK-3475) as first-line therapy for PD-L1–positive metastatic non-small cell lung cancer (NSCLC): Updated data from KEYNOTE-001. 2015 ·Journal of Clinical Oncology ·Naiyer A. Rizvi,Edward B. Garon,Natasha B. Leighl,Matthew D. Hellmann,Amita Patnaik,Leena Gandhi,Joseph P. Eder,Reshma Rangwala,Gregory M. Lubiniecki,Jin Zhang,Kenneth Emancipator,Charlotte Roach,Ruth Z. Rutledge,Rina Hui,Myung‐Ju Ahn,Leora Horn,Enriqueta Felip,Enric Carcereny	18
3	Identification of a novel RAMP-independent CGRP receptor antagonist 2011 ·Bioorganic & Medicinal Chemistry Letters ·C. Blair Zartman,Ian M. Bell,Steven N. Gallicchio,Samuel Graham,Stefanie A. Kane,John Mallee,Ruth Z. Rutledge,Christopher Salvatore,Joseph P. Vacca,Theresa M. Williams	2
4	Caprolactams as potent CGRP receptor antagonists for the treatment of migraine 2007 ·Bioorganic & Medicinal Chemistry Letters ·Anthony W. Shaw,Daniel V. Paone,Diem N. Nguyen,Craig A. Stump,Christopher S. Burgey,Scott D. Mosser,Christopher Salvatore,Ruth Z. Rutledge,Stefanie A. Kane,Kenneth S. Koblan,Samuel Graham,(unknown),Theresa M. Williams	31
5	A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax 2007 ·Clinical and Vaccine Immunology ·(unknown),(unknown),(unknown),Tina M. Sterling,Ruth Z. Rutledge,Doreen Fernsler,Neal Azrolan,Santosh Sutradhar,(unknown),Ivan S. F. Chan,Katia Schlienger,F. Schödel,Jeffrey L. Silber	46
6	Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead 2006 ·Bioorganic & Medicinal Chemistry Letters ·Theresa M. Williams,Craig A. Stump,Diem N. Nguyen,(unknown),Ian M. Bell,Steven N. Gallicchio,C. Blair Zartman,Bang-Lin Wan,Kimberly Della Penna,Priya Kunapuli,Stefanie A. Kane,Ken S. Koblan,Scott D. Mosser,Ruth Z. Rutledge,Christopher Salvatore,John F. Fay,Joseph P. Vacca,Samuel Graham	39
7	Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: Optimization of the 4-substituted piperidine 2006 ·Bioorganic & Medicinal Chemistry Letters ·Christopher S. Burgey,Craig A. Stump,Diem N. Nguyen,James Z. Deng,(unknown),(unknown),Ian M. Bell,Scott D. Mosser,Christopher Salvatore,Ruth Z. Rutledge,Stefanie A. Kane,Kenneth S. Koblan,Joseph P. Vacca,Samuel Graham,Theresa M. Williams	40
8	The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau,(unknown),Georgia B. McGaughey,Kathleen Coll,(unknown),William F. Hoffman,Randall W. Hungate,Richard Kendall,Rosemary C. McFall,Keith Rickert,Ruth Z. Rutledge,Kenneth A. Thomas	27
9	Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau,(unknown),(unknown),(unknown),Kathleen Coll,William R. Huckle,Randall W. Hungate,Richard Kendall,Rosemary C. McFall,Xianzhi Mao,Ruth Z. Rutledge,Kenneth A. Thomas	13
10	Discovery and evaluation of 3-(5-Thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley,Kenneth L. Arrington,(unknown),William F. Hoffman,(unknown),Mary Beth Young,Randall W. Hungate,Andrew J. Tebben,Ruth Z. Rutledge,Richard Kendall,William R. Huckle,Rosemary C. McFall,Kathleen Coll,Kenneth A. Thomas	13
11	Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley,William F. Hoffman,Robert S. Rubino,Randall W. Hungate,Andrew J. Tebben,Ruth Z. Rutledge,Rosemary C. McFall,William R. Huckle,Richard Kendall,Kathleen Coll,Kenneth A. Thomas	105
12	Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells 2002 ·European Journal of Pharmacology ·Lars Edvinsson,Rikard Alm,Duncan Shaw,Ruth Z. Rutledge,Kenneth S. Koblan,Jenny Longmore,Stefanie A. Kane	94
13	Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics 2002 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley,Robert S. Rubino,William F. Hoffman,(unknown),Kenneth L. Arrington,Randall W. Hungate,Mark T. Bilodeau,Andrew J. Tebben,Ruth Z. Rutledge,Richard Kendall,Rosemary C. McFall,William R. Huckle,Kathleen Coll,Kenneth A. Thomas	79
14	Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries 2001 ·European Journal of Pharmacology ·Lars Edvinsson,Anette Sams,Inger Jansen‐Olesen,János Tajti,Stefanie A. Kane,Ruth Z. Rutledge,Kenneth S. Koblan,R.G. Hill,Jenny Longmore	56
15	Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues 1999 ·Journal of Biological Chemistry ·Richard Kendall,Ruth Z. Rutledge,Xianzhi Mao,Andrew J. Tebben,Randall W. Hungate,Kenneth A. Thomas	99
16	RPR 107393, a Potent Squalene Synthase Inhibitor and Orally Effective Cholesterol-Lowering Agent: Comparison with Inhibitors of HMG-CoA Reductase 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Dilip Amin,Ruth Z. Rutledge,Saul Needle,Helen Galczenski,Kent Neuenschwander,(unknown),Martin P. Maguire,Raymond C. Bush,David J Hele,Glenda E. Bilder,Mark H. Perrone	60

About Ruth Z. Rutledge

Ruth Z. Rutledge is a scholar working on Psychiatry and Mental health, Oncology and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 735 indexed citations. Recurring topics across this work include Migraine and Headache Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Psychiatry and Mental health (175 citations), Cellular and Molecular Neuroscience (155 citations) and Organic Chemistry (211 citations). Ruth Z. Rutledge has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Kenneth A. Thomas, Randall W. Hungate, Richard Kendall, Andrew J. Tebben, Stefanie A. Kane, Kenneth S. Koblan, Lars Edvinsson, Jenny Longmore, Kathleen Coll and Rosemary C. McFall. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact